Table 3.4 Reported cases of laboratory-confirmed, chronic hepatitis B virus (HBV) infection, by sex, race/ethnicity, age group, and case criteria — Enhanced Viral Hepatitis Surveillance Sites, 2010

Category
CO
No. (%)
CT
No. (%)
MN
No. (%)
NM
No. (%)
NY
State
No. (%)
NY
City
No. (%)
OR
No. (%)
San
Francisco
No. (%)
Total
No. (%)
Sex
Female
93
(52.0)
160
(43.0)
318
(48.3)
24
(45.3)
294
(38.2)
3161
(43.4)
154
(48.9)
405
(45.9)
4609
(38.5)
Male
86
(48.0)
212
(57.0)
334
(50.8)
29
(54.7)
476
(61.8)
4125
(56.6)
159
(50.5)
473
(53.6)
5894
(49.3)
Missing
0
(0.0)
0
(0.0)
6
(0.9)
0
(0.0)
0
(0.0)
0
(0.0)
2
(0.6)
4
(0.5)
12
(0.1)
Race/Ethnicity*
AI / AN
0
(0.0)
0
(0.0)
2
(0.3)
2
(3.8)
1
(0.1)
2
(0.0)
7
(2.2)
0
(0.0)
14
(0.1)
API
88
(49.2)
144
(38.7)
229
(34.8)
19
(35.9)
253
(32.9)
1447
(19.9)
156
(49.5)
507
(57.5)
2843
(23.8)
Black
29
(16.2)
63
(16.9)
165
(25.1)
5
(9.4)
127
(16.5)
511
(7.0)
16
(5.1)
15
(1.7)
931
(7.8)
White
25
(14.0)
73
(19.6)
43
(6.5)
12
(22.6)
109
(14.2)
142
(2.0)
80
(25.4)
25
(2.8)
509
(4.3)
Hispanic
8
(4.5)
34
(9.1)
4
(0.6)
9
(17.0)
31
(4.0)
113
(1.6)
10
(3.2)
8
(0.9)
217
(1.8)
Other
2
(1.1)
4
(1.1)
6
(0.9)
0
(0.0)
12
(1.6)
0
(0.0)
5
(1.6)
11
(1.3)
40
(0.3)
Unknown / Missing
27
(15.1)
54
(14.5)
209
(31.8)
6
(11.3)
237
(30.8)
5071
(69.6)
41
(13.0)
316
(35.8)
5961
(49.8)
Age group (yrs)
0-14
13
(7.3)
4
(1.1)
24
(3.7)
1
(1.9)
20
(2.6)
81
(1.1)
13
(4.1)
6
(0.7)
162
(1.4)
15-24
20
(11.2)
28
(7.5)
95
(14.4)
4
(7.6)
68
(8.8)
689
(9.5)
29
(9.2)
24
(2.7)
957
(8.0)
25-39
80
(44.7)
137
(36.8)
291
(44.2)
13
(24.5)
241
(31.3)
3134
(43.0)
102
(32.4)
259
(29.4)
4257
(35.6)
40-54
32
(17.9)
128
(34.4)
165
(25.1)
25
(47.2)
256
(33.3)
2200
(30.2)
108
(34.3)
299
(33.9)
3213
(26.9)
55+
34
(19.0)
75
(20.2)
83
(12.6)
10
(18.9)
185
(24.0)
1182
(16.2)
63
(20.0)
294
(33.3)
1926
(16.1)
Missing
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
Place of Birth
United States
23
(12.9)
32
(8.6)
24
(3.7)
U
(U)
53
(6.9)
12
(0.2)
60
(19.1)
26
(3.0)
230
(1.9)
Outside US
103
(57.5)
159
(42.7)
418
(63.5)
U
(U)
194
(25.2)
197
(2.7)
149
(47.3)
140
(15.9)
1360
(11.4)
Missing/
Unknown
53
(29.6)
181
(48.7)
216
(32.8)
U
(U)
523
(67.9)
7077
(97.1)
106
(33.7)
716
(81.2)
8872
(74.2)
Case criteria†
Hepatitis B surface antigen
176
(98.3)
372
(100.0)
644
(97.9)
U
(U)
740
(96.1)
6939
(95.2)
273
(86.7)
835
(94.7)
9979
(83.4)
Hepatitis B e-antigen
36
(20.1)
48
(12.9)
129
(19.6)
U
(U)
161
(20.9)
1449
(19.9)
26
(8.3)
101
(11.5)
1950
(16.3)
HBV-DNA
51
(28.5)
148
(39.8)
397
(60.3)
U
(U)
464
(60.3)
5564
(76.4)
36
(11.4)
544
(61.7)
7204
(60.2)
Total new
reported cases
179 372 658 53 770 7,286 315 882 10,515
Estimated 2010
population
5,029,196 3,574,097 5,303,925 2,059,179 11,202,969 8,175,133 3,831,074 805,235 39,980,808
Rate per 100,000 population
3.6 10.4 12.4 2.6 6.9 89.1 8.2 109.5 26.3

*Categorized in the following order: 1) Hispanic; 2) AI/AN; 3) API; 4) Black; 5) White; 6) Other;
† Cases can be reported with more than one laboratory test result
U=No data available for reporting